Efficacy and Safety With Ziprasidone in First-episode Psychosis

Chonbuk National University

Status and phase: Completed; Phase 4

Conditions: First Episode Psychosis

Treatments: Drug: Ziprasidone

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT01157559

2006-Zeldox in FEP

Details and patient eligibility

About

The aim of the study is to investigate the efficacy and safety of ziprasidone in patients with first episode psychosis.

Enrollment: 27 patients

Sex: All

Ages: 14 to 45 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients who meet DSM-IV criteria for first episode schizophrenia, schizophreniform disorder and schizoaffective disorder

Exclusion criteria

• Patients with previously prescribed antipsychotic medication in 2 weeks or more
• patients with substance-induced psychotic disorder, serious suicide attempt, neurological disorder, etc.

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)